Previous 10 | Next 10 |
Baillie Gifford’s 13F portfolio value decreased from ~$182B to ~$143B this quarter. They increased Affirm Holdings, Coupang, and Ginkgo Bioworks while reducing Petroleo Brasileiro and First Republic Bank. The top three positions are Tesla Motors, Moderna, and Illumina, and ...
National Safety Council and Pacira BioSciences Partner to Launch an Employee-Based Program Focused on Opioid Use and Misuse PR Newswire Initiative educates employees and their family members on the importance of preventing opioid misuse and addiction ITASCA, ...
Pacira BioSciences (NASDAQ:PCRX) has reported prelim May net product sales for EXPAREL® (bupivacaine liposome injectable suspension) and iovera. EXPAREL net product sales grew from $41.2M in May 2021 to $44.9M; average daily sales were 104% of May 2021. Net product sales of iovera were $...
TAMPA, Fla., June 14, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported preliminary unaudited net product sales for EXPAREL ® (bupivacaine liposome ...
TAMPA, Fla., June 02, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the Jefferies Healthcare Conference at 9:00 AM ET on Thursday, June 9, 2022 in New York. Live audio of the event can be acce...
The Carillon Family of Funds spans a range of investment objectives and asset classes designed for long-term investors. Inflation concerns and accelerating expectations of interest rate hikes by the U.S. Federal Reserve sent equity markets in a downward spiral to start the new year. ...
Pacira BioSciences and the National Senior Games Association Break a GUINNESS WORLD RECORDS™ Title for the Largest Game of Freeze Dance PR Newswire More than 1,300 participants joined the recording-breaking game held at the 2022 National Senior Games Celebrati...
John Paulson’s 13F portfolio value increased marginally from $3.24B to $3.25B this quarter. Paulson & Company added SPDR Gold Trust ETF while reducing Pacira BioSciences and TIM S.A. They also dropped Shell plc and TotalEnergies SE. The top three positions are at 43% of...
John Paulson's fund, Paulson & Co. reported its 13F filing for Q2 wherein it added Agnico Eagle Mines (AEM) and SPDR Gold Trust ETF (GLD) in new positions It increased its stakes in Bausch Health (BHC), Horizon Therapeutics (HZNP), BrightSphere Investment (BSIG), NovaGold Resources (NG), ...
TAMPA, Fla., May 12, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported preliminary unaudited net product sales for EXPAREL ® (bupivacaine lipo...
News, Short Squeeze, Breakout and More Instantly...
Pacira BioSciences Inc. Company Name:
PCRX Stock Symbol:
NASDAQ Market:
Pacira BioSciences Inc. Website:
-- Proposed Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment System Rule extends separate payment from ambulatory surgical centers to include the hospital outpatient environment – -- Rule implements the NOPAIN Act, signed into law as part of the Cons...
A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 86.1% to $0.514 on volume of 587,366,807 shares NVIDIA Corporation (NVDA) fell 1.3% to $122.67 on volume of 214,038,378 shares Tesla Inc. (TSLA) rose 10.2% to $231.26 on volume of 201,850,947 ...
2024-07-02 14:00:06 ET Oren Livnat from H.C. Wainwright issued a price target of $57.00 for PCRX on 2024-07-02 12:36:00. The adjusted price target was set to $57.00. At the time of the announcement, PCRX was trading at $21.91. The overall price target consensus is at $48...